Rama Phosphates (RAMAPHO)

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Return on equity of 14.50% with low debt-to-equity of 0.26 shows decent profitability without excessive leverage
• Attractive valuation: P/E of 8.55 and P/B of 1.31, with book value of ₹103.89 against price of ₹136.19
• Latest quarter net profit of ₹14 Cr annualizes to roughly ₹56 Cr, supporting a modest earnings multiple
• Promoter holding of 75% aligns management with minority shareholders
• Piotroski F-score of 7/9 indicates solid financial health and improving fundamentals

Concerns

• Fertilizers are a commodity, cyclical business with limited pricing power and heavy dependence on government policy and subsidies
• ROCE of 7.81% is modest, suggesting capital is not being deployed very efficiently
• Profit growth of 283% is likely from a low base or a cyclical peak, not a durable long-term trend
• Dividend yield of only 0.39% provides little income cushion while waiting for value to be realized

AI Analysis

Let me look at Rama Phosphates the way I look at any business. It sells fertilizers, a commodity input for farmers. That immediately tells me there is no wide economic moat here. Customers will switch to cheaper products, and pricing is heavily influenced by government subsidy and global input costs. So this is not a wonderful business in the Buffett sense. But at ₹136.19, with a market cap of ₹449 Cr, the price gives me some protection. The trailing P/E is only 8.55, and book value is ₹103.89, so I am paying just 1.31 times book. Return on equity is 14.50%, while debt-to-equity is only 0.26, so the company is not loaded with leverage. Promoters holding 75% is a good sign; their interests are aligned with mine. The profit growth of 283% and sales growth of 32.5% are eye-catching, but I am suspicious. In cyclical industries, a bumper year often tempts investors to extrapolate. I prefer to ask whether the latest quarter’s net profit of ₹14 Cr can be maintained. Annualized, that is roughly ₹56 Cr, so the stock is priced around 8 times that run-rate. That is not expensive, but it assumes current conditions continue. The PEG ratio of 0.05 is meaningless here because it extrapolates a cyclical bounce. ROCE of 7.81% is not impressive, and the dividend yield of 0.39% means I am not being paid to wait. The Piotroski F-score of 7/9 tells me financial health is above average, and low debt gives the company staying power. If farm economics remain good and input costs stay controlled, this could be a reasonable value proposition. But I would not mistake a strong cyclical upswing for durable growth. If the cycle turns, a low P/E can become a value trap. I will keep it on my watchlist.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer